Jump to content
  • Sign Up
0
Scott Adams

Efficacy Data from Phase 2a Trial of ALV003 in Celiac Disease Patients - Celiac.com

Rate this topic

Recommended Posts

6.jpg

Celiac.com

Efficacy Data from Phase 2a Trial of ALV003 in Celiac Disease Patients

Celiac.com

Celiac.com 12/13/2011 - Alvine Pharmaceuticals, Inc. has announced that efficacy data from its Phase 2a clinical trial of ALV003 shows that oral ALV003, administered as part of a gluten free diet, reduced gluten-induced intestinal mucosal damage in ...

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×